XML 32 R25.htm IDEA: XBRL DOCUMENT v3.25.3
Accounting for Stock-Based Compensation (Tables)
9 Months Ended
Sep. 30, 2025
Share-Based Payment Arrangement [Abstract]  
Schedule of Share-based Compensation Expense

The following table reflects the impact of total compensation expense related to stock-based equity plans on the reported operating results for the respective periods (in millions):

 

 

 

Three Months Ended

 

 

Nine Months Ended

 

 

 

September 30,

 

 

September 30,

 

 

 

2025

 

 

2024

 

 

2025

 

 

2024

 

Effect on income (loss) before income taxes

 

$

1

 

 

$

(5

)

 

$

(7

)

 

$

(12

)

Effect on net income (loss)

 

$

 

 

$

(4

)

 

$

(5

)

 

$

(10

)

Schedule of Share-based Payment Awards, Stock Options, Valuation Assumptions

The fair value of stock options was estimated using the Black Scholes option pricing model with the following assumptions and weighted-average fair values during the three and nine months ended September 30, 2025 and 2024:

 

 

 

Three Months Ended
September 30,

 

Nine Months Ended
September 30,

 

 

2025

 

2024

 

2025

 

2024

Expected volatility

 

N/A

 

N/A

 

88.7%

 

90.1%

Expected dividends

 

N/A

 

N/A

 

 

Expected term

 

N/A

 

N/A

 

6 years

 

6 years

Risk-free interest rate

 

N/A

 

N/A

 

4.0%

 

4.3%

Schedule of Share-based Compensation, Stock Options, Activity

Options outstanding and exercisable under the 2009 Plan as of September 30, 2025, and changes during each of the three-month periods following December 31, 2024, were as follows (in millions, except share and per share data):

 

 

 

 

 

 

 

 

 

Weighted-

 

Aggregate

 

 

 

 

 

 

Weighted-

 

 

Average

 

Intrinsic

 

 

 

 

 

 

Average

 

 

Remaining

 

Value as of

 

 

 

 

 

 

Exercise

 

 

Contractual

 

September 30,

 

 

 

Shares

 

 

Price

 

 

Term

 

2025

 

Outstanding at December 31, 2024

 

 

4,490,750

 

 

$

6.24

 

 

 

 

 

 

Granted

 

 

806,000

 

 

 

3.01

 

 

 

 

 

 

Exercised

 

 

 

 

 

 

 

 

 

 

 

Forfeited and cancelled

 

 

(57,000

)

 

 

4.43

 

 

 

 

 

 

Outstanding at March 31, 2025

 

 

5,239,750

 

 

 

5.77

 

 

 

 

 

 

Granted

 

 

 

 

 

 

 

 

 

 

 

Exercised

 

 

 

 

 

 

 

 

 

 

 

Forfeited and cancelled

 

 

(310,750

)

 

 

6.45

 

 

 

 

 

 

Outstanding at June 30, 2025

 

 

4,929,000

 

 

 

5.72

 

 

 

 

 

 

Granted

 

 

 

 

 

 

 

 

 

 

 

Exercised

 

 

 

 

 

 

 

 

 

 

 

Forfeited and cancelled

 

 

 

 

 

 

 

 

 

 

 

Outstanding at September 30, 2025

 

 

4,929,000

 

 

$

5.72

 

 

6.7 years

 

$

 

Exercisable at September 30, 2025

 

 

3,330,989

 

 

$

6.81

 

 

5.7 years

 

$

 

Schedule of Share-based Compensation, Restricted Stock, Activity

Restricted stock outstanding under the 2009 Plan as of September 30, 2025, and changes during each of the three-month periods following December 31, 2024, were as follows:

 

 

 

 

 

 

Weighted-

 

 

 

 

 

 

Average Grant

 

 

 

Shares

 

 

Date Fair Value

 

Unvested at December 31, 2024

 

 

6,509,245

 

 

$

5.63

 

Granted

 

 

2,636,000

 

 

 

3.01

 

Vested

 

 

(1,582,989

)

 

 

6.56

 

Forfeited

 

 

(1,004,170

)

 

 

9.66

 

Unvested at March 31, 2025

 

 

6,558,086

 

 

 

3.74

 

Granted

 

 

27,000

 

 

 

3.88

 

Vested

 

 

(48,003

)

 

 

4.14

 

Forfeited

 

 

(205,002

)

 

 

3.80

 

Unvested at June 30, 2025

 

 

6,332,081

 

 

 

3.74

 

Granted

 

 

 

 

 

 

Vested

 

 

 

 

 

 

Forfeited

 

 

 

 

 

 

Unvested at September 30, 2025

 

 

6,332,081

 

 

 

3.74

 

Schedule of Share-based Compensation, Restricted Stock Units, Activity

RSUs outstanding under the 2009 Plan as of September 30, 2025, and changes during each of the three-month periods following December 31, 2024, were as follows:

 

 

 

 

 

 

Weighted-

 

 

 

 

 

 

Average Grant

 

 

 

Shares

 

 

Date Fair Value

 

Outstanding at December 31, 2024

 

 

1,548,316

 

 

$

4.49

 

Granted

 

 

777,413

 

 

 

3.01

 

Vested

 

 

(249,998

)

 

 

4.80

 

Forfeited

 

 

 

 

 

 

Unvested at March 31, 2025

 

 

2,075,731

 

 

 

3.90

 

Granted

 

 

 

 

 

 

Vested

 

 

(5,894

)

 

 

5.00

 

Forfeited

 

 

 

 

 

 

Unvested at June 30, 2025

 

 

2,069,837

 

 

 

3.90

 

Granted

 

 

 

 

 

 

Vested

 

 

 

 

 

 

Forfeited

 

 

 

 

 

 

Unvested at September 30, 2025

 

 

2,069,837

 

 

 

3.90